The Genetics of Type I and Type II Diabetes: Analysis by Recombinant DNA Methodology
Susceptibility to IDDM is linked to the HLA-D locus on the short arm of chromosome 6, a region believed to be involved in the process of communication between cells which determines immune responses. Presumably an HLA molecule encoded by this region, unable to present a particular antigenic pathogen to the immune system, is inherited. The HLA-DR locus is quite complex, however. The gene which codes for this defective molecule may be identified by a combination of use of monoclonal antibodies and cloned gene probes which specifically hybridize to various portions of this region. Investigators are searching for HLA-DR4 containing chromosomes in IDDM which show similar patterns of restriction enzyme polymorphism. Hopefully, complete structural analysis of these related sequences will provide information about the mechanisms which confer susceptibility to develop IDDM.
A strong genetic component is involved in NIDDM evidenced by a high concordance in monozygotic twins. Nevertheless, there is much evidence of genetic heterogeneity. At the present time no clear cut genetic marker has been defined. The human insulin gene has been cloned and by Southern blot hybridization analysis of peripheral leukocyte DNA, the insulin gene locus is being evaluated as a possible contributor to the genetic defect. Population studies at the present time have not identified any particular polymorphic insulin allele associated with NIDDM. Population studies are complicated by heterogeneity of NIDDM, racial and ethnic differences, and heterogeneity of insulin alleles. Linkage analysis in family studies will provide an alternative approach to population studies to determine what role if any the insulin gene plays in the genetic component of this disease. Because NIDDH is heterogeneous and perhaps polygenic in nature, these linkage analyses in families with NIDDM can be extended to other genes when they are cloned such as that coding for the insulin receptor.
The familial aggregation of diabetes has long been noted (see ref. 1 for review). In relatives of diabetics, the prevalence ranges from 10–30%, while it is variously estimated to be between 0.1–3% in the general population. But familial aggregation of a trait may be caused either by genetic or environmental factors. One approach to dissecting the contribution of these factors is the study of concordance in twins. Pyke and associates2 observed that overall identical twins always show a higher concordance rate than dizygotic twins, irrespective of their age of diagnosis. Furthermore, they noted that identical twins of younger onset are often discordant for diabetes while identical twins of older onset are usually concordant. In a study of 200 pairs of monozygotic twins,3 the concordance of Type I or insulin dependent diabetes (IDDM) was 80 of 147 twin pairs (54%). In contrast, 48 of 53 Type II or non-insulin dependent diabetes (NIDDH) pairs (91%) were concordant for diabetes. Thus, while genetic factors are important in both types of diabetics, a strong environmental component makes genetic analysis of IDDH more complex.
KeywordsCholesterol Obesity Recombination Serine Polypeptide
Unable to display preview. Download preview PDF.
- 1.J.I. Rotter, and D.L. Rimoin, Genetics, in: “Handbook of Diabetes Mellitus,” M. Brownlee, ed., Gorland STPM Press, New York (1980).Google Scholar
- 2.R.B. Tattersall, D.A. Pyke, Diabetes in identical twins, Lancet ii: 1120–1125 (1972).Google Scholar
- 4.J. Neurp, P. Platz, O. Ortved-Anderson, M. Christy, J. Egeberg, J. Lyngsoe, J.E. Poulsen, L.P. Ryder, M. Thomsen, and A. Svejgaard, in: “The Genetics of Diabetes Mellitus,” W. Creutzfeldt, J. Kobberling, and J. V. Neel, eds., SpringerVerlag (1976).Google Scholar
- 5.H. Thomsen, P. Platz, 0.0. Andersen, M. Christy, J. Lyngsoe, J. Nerup, K. Rasmussen, L.P. Ryder, L.S. Nielsen, and A. Sveigaard, MLC typing in juvenile diabetes mellitus and idiopathic Addison’s disease, Transplant Res. 22: 125–147 (1975).Google Scholar
- 8.J. Neurp, M. Christy, A. Green, M. Hauge, P. Platz, L.P. Ryder, A. Svejgaard, and H.L. Thomsen, HLA and insulin dependent diabetes - population studies, in: “The Genetics of Diabetes Mellitus. Serono Symposium. Vol 47,” J. Kobberling and R. Tattersall, eds., Academic Press (1982).Google Scholar
- 9.A.N. Gorsuch, K.H. Spencer, E. Wolf, and A.G. Cudworth, HLA and family studies, in: “The Genetics of Diabetes Mellitus. Serono Symposium. Vol. 47,” J. Kobberling and R. Tattersall, eds., Academic Press (1982).Google Scholar
- 13.J.F. Gusella, N.S. Wexler, P.H. Conneally, S.L. Naylor, M.A. Anderson, R.E. Tanzi, P.C. Watkins, K. Ottina, H.R. Wallace, A.Y. Sakaguchi, A.B. Young, I. Shoulson, E. Bonilla, and J.S. Martin, A polymorphic DNA marker genetically linked to Huntington’s disease, Nature 306: 234–238 (1983).PubMedCrossRefGoogle Scholar
- 15.D. Owerbach, B. Hagglof, A. Lernmark, and G. Holmgren, Susceptibility in insulin-dependent diabetes defined by restriction enzyme polymorphism of HLA-D region genomic DNA, Submitted to Diabetes. Google Scholar
- 17.J.D. Baird, Is obesity a factor in the aetiology of noninsulindependent diabetes?, in: “The Genetics of Diabetes Mellitus. Serono Symposim. Vol. 47,” J. Kobberling, and R. Tattersall, eds., Academic Press (1982).Google Scholar
- 18.J. Kobberling, Genetic heterogeneities with idiopathic diabetes, in: “The Genetics of Diabetes Mellitus,” W. Creutzfeldt, J. Kobberling, and J.V. Neel, eds. Springer-Verlag, Berlin (1976).Google Scholar
- 19.P.Z. Zimmet, R.L. Kirk, and S.W. Serjeantson, Genetic and environmental interactions for non-insulin-dependent diabetes in high prevalence Pacific populations, in: “The Genetics of Diabetes Mellitus. Serono Symposium. Vol 47,” J. Kobberling, and R. Tattersall, eds., Academic Press, (1982).Google Scholar
- 20.W.C. Knowler, P.J. Savage, M. Nagulesparan, B.V. Howar, D.J. Pettitt, J.R. Lisse, S.L. Aronoff, and P.H. Bennett, Obesity, insulin resistance and diabetes mellitus in the Pima Indians, in: “The Genetics of Diabetes Mellitus. Serono Symposium. Vol. 47,” J. Kobberling and R. Tattersall, eds., Academic Press (1982).Google Scholar
- 26.S.N.T. Fui, H. Keen, J. Jarrett, V. Gossain, and P. Marsden, Test for Chlorpropamide-alcohol flush becomes positive after prolonged chlorpropamide treatment in insulin-depedent and noninsulin dependent diabetics, New Engl. J. Med. 309: 93–96 (1983).Google Scholar
- 28.R.L. White, D. Barker, T. Holm, J. Berkowitz, M. Lepert, W. Cavenee, R. Leach, and D. Drayna, Approaches to linkage analysis in the human, in: “Banbury Report 14. Recombination DNA Applications to Human Disease,” C.T. Caskey, and R.L. White, eds., Cold Spring Harbor Laboratory (1983).Google Scholar
- 36.P.S. Rotwein, J. Chirgwin, M. Province, W.C. Knowler, D.J. Pettitt, B. Cordell, H.M. Goodman, and H.A. Permutt, Polymorphism in the 5’-flanking region of the human insulin gene: A genetic marker for non-insulin-dependent diabetes, New Engl. J. Med. 308: 65–71 (1983).Google Scholar
- 41.T. Mandrup-Poulsen, D. Owerbach, S.A. Mortensen, K. Johansen, H. Meinertz, H. Sorensen, and J. Nerup, DNA-sequences flanking the insulin gene on chromosome 11 confer risk of atherosclerosis, Lancet 1: 250–252 (1984).Google Scholar
- 46.W.C. Knowler, D.J. Pettitt, B. Vasquez, P.S. Rotwein, T.L. Andreone, and M.A. Permutt, Polymorphism in the S’-flanking region of the human insulin gene: Relationships with non-insulin-dependent diabetes mellitus, glucose and insulin concentrations, and diabetes treatment in the Pima Indians. J. Clin. Invest. 74: 2129 (1984).PubMedCrossRefGoogle Scholar
- 47.T. Andreone, S. Fajans, P. Rotwein, W. Skolnick, and M.A. Permutt, Insulin gene analysis in a family with maturity onset diabetes of the young. Diabetes (in press).Google Scholar